5 Recruiting Non-Hodgkin's Lymphoma Phase 1 Clinical Trials
Active phase 1 studies for non-hodgkin's lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Non-Hodgkin's Lymphoma studiesPhase 1 Studies for Non-Hodgkin's Lymphoma
🔵 Active, Not Recruiting Phase1
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Early Phase1
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
📍 University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
📍 Carolina BioOncology Institute /ID# 265259 — Huntersville, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔